What is Globus Medical, Inc. (GMED)?

Globus Medical, Inc. (GMED) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of GMED?

The current price of GMED is $81.26. Prices are updated in real time on Stocks360.

What is GMED's price-to-earnings (PE) ratio?

GMED's trailing twelve-month PE ratio is 20.47, based on current price and earnings per share data available on Stocks360.

What is GMED's market capitalization?

GMED's market capitalization is $10,910,123,700.00, placing it in the large-cap tier.

Globus Medical, Inc. (GMED)

Stock analysis · NYSE · Healthcare · Medical - Devices

$81.26

Market Cap

$10.91B

PE (TTM)

20.47

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.96

Day Range

$80.23 – $81.73

52-wk Range

$59.51 – $101.40

Avg Volume

N/A

Volume

772.38K

Globus Medical, Inc. (GMED) is a publicly traded company in the Healthcare sector. Latest price: $81.26. Market cap $10.91B. Trailing PE 20.47. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $61.48 2026-10-28 · $81.26 (+32.17%)

Earnings

Most Recent

Aug 6, 2026

EPS $1.34 vs est. $1.10

Beat by $0.24

Next Earnings

Nov 5, 2026

EPS estimate $1.20

Proprietary Signals

Signal snapshot temporarily unavailable.

About Globus Medical, Inc.

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, aceta…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	20.47×
P/S (TTM)	3.47×
P/B	2.31×
PEG	0.40×
P/FCF (TTM)	14.54×
EV / EBITDA	11.12×
EV / Sales	3.34×
Earnings Yield	4.87%
Free Cash Flow Yield	6.88%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$10.51B
Revenue (TTM)	$3.14B
Net Income (TTM)	$531.10M
Free Cash Flow (TTM)	$755.59M
Net Debt	-$396.55M
Working Capital	$1.74B
Gross Margin	68.55%
Operating Margin	20.75%
Net Margin	17.03%
Return on Equity	11.59%
Return on Invested Capital	10.46%